Delphia (Usa) Inc. Vir Biotechnology, Inc. Transaction History

Delphia (Usa) Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$19.08 - $26.7 $253,306 - $354,469	-13,276 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$21.19 - $40.01 $155,365 - $293,353	7,332 Added 123.35%	13,276 $341,000
Q4 2021 Feb 14, 2022	BUY	$30.97 - $54.03 $184,085 - $321,154	5,944 New	5,944 $249,000

233

87.6M

231K

132K

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $999M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Delphia (Usa) Inc., based on Form 13F filings with the SEC.

Stay updated on Delphia (Usa) Inc. with notifications on news.